ACTRN12623000101684招募中未知
An adaptive trial design evaluating use of varying wait lists on the severity of disordered eating in people with non-underweight eating disorders
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 86
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 15 Years 至 o limit(—)
- 性别
- All
入选标准
- •(1) age 15 years and above; (2) body mass index greater than or equal to 18.5; (3) a DSM-5 eating disorder diagnosis excluding binge eating disorder; and (4) involvement of the general practitioner.
排除标准
- •substance dependence, active psychosis, high suicidality, or difficulty understanding or speaking English
研究者
相似试验
进行中(未招募)
Unknown
earning Together Primary Schools pilot randomized controlled trialPrevention of bullying among primary school studentsISRCTN10215449ondon School of Hygiene & Tropical Medicine1,059
进行中(未招募)
不适用
A randomized, adaptive-design dose finding study to assess the antiviral efficacy andsafety of NIM811 administered in combination with Standard of Care (SOC) for 12 weeks in relapsed HCV-1 infected patientsEUCTR2009-009995-11-DEovartis Pharma Services AG50
进行中(未招募)
不适用
A randomized, adaptive-design dose finding study to assess the antiviral efficacy andsafety of NIM811 administered in combination with Standard of Care (SOC) for 12 weeks in relapsed HCV-1 infected patientsEUCTR2009-009995-11-BEovartis Pharma Services AG50
已完成
2 期
A randomized, adaptive-design dose finding study to assess the antiviral efficacy and safety of NIM811 administered in combination with Standard of Care (SOC) in relapsed HCV-1 infected patientsHepatitis CNL-OMON33087ovartis10
进行中(未招募)
不适用
A randomized, adaptive-design dose finding study to assess the antiviral efficacy andsafety of NIM811 administered in combination with Standard of Care (SOC) in relapsed HCV-1 infected patientsHepatitis C genotype 1 relapserMedDRA version: 9.1Level: LLTClassification code 10019744Term: Hepatitis CEUCTR2009-009995-11-NLovartis Pharma Services AG250
